https://www.selleckchem.com/products/jdq443.html
001). Overall, cancer-specific and relapse-free survival rates were lower in the vasohibin-1-positive (P = 0.034, P less then 0.001, P = 0.002, respectively) and high vasohibin-2 expression (P = 0.004, P = 0.003, P less then 0.001, respectively) groups. Multivariate analysis revealed that vasohibin-1 expression was associated with cancer-specific (P = 0.014, hazard ratio [HR] 4.454) and relapse-free (P = 0.035, HR 2.557) survival and vasohibin-2 expression tended to influence relapse-free survival (P = 0.051, HR 2.061). Grouping patients
Like
Comment
Share
